GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells
Pompe disease is a metabolic myopathy caused by deficiency of the acid α-glucosidase (GAA) enzyme and results in progressive wasting of skeletal muscle cells. The c.-32-13T>G (IVS1) GAA variant promotes exon 2 skipping during pre-mRNA splicing and is the most common variant for the childhood/adul...
Saved in:
Main Authors: | Erik van der Wal (Author), Atze J. Bergsma (Author), Tom J.M. van Gestel (Author), Stijn L.M. in 't Groen (Author), Holm Zaehres (Author), Marcos J. Araúzo-Bravo (Author), Hans R. Schöler (Author), Ans T. van der Ploeg (Author), W.W.M. Pim Pijnappel (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe Disease
by: Erik van der Wal, et al.
Published: (2017) -
From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides
by: Atze J Bergsma, et al.
Published: (2016) -
Potential of iPSC-Derived Mesenchymal Stromal Cells for Treating Periodontal Disease
by: K. Hynes, et al.
Published: (2018) -
Thyroid hormone receptor beta (THRβ1) is the major regulator of T3 action in human iPSC-derived hepatocytes
by: Lorraine Soares De Oliveira, et al.
Published: (2024) -
iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity
by: Tim Y. T. Lee, et al.
Published: (2024)